SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-19-010680
Filing Date
2019-11-12
Accepted
2019-11-12 07:34:35
Documents
59
Period of Report
2019-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q akro-20190930x10q.htm 10-Q 1868369
2 EX-31.1 akro-20190930ex311dab478.htm EX-31.1 11744
3 EX-31.2 akro-20190930ex31272877c.htm EX-31.2 12677
4 EX-32.1 akro-20190930ex3219b91eb.htm EX-32.1 10771
  Complete submission text file 0001558370-19-010680.txt   5185371

Data Files

Seq Description Document Type Size
5 EX-101.INS akro-20190930.xml EX-101.INS 787257
6 EX-101.SCH akro-20190930.xsd EX-101.SCH 42978
7 EX-101.CAL akro-20190930_cal.xml EX-101.CAL 31432
8 EX-101.DEF akro-20190930_def.xml EX-101.DEF 120052
9 EX-101.LAB akro-20190930_lab.xml EX-101.LAB 363600
10 EX-101.PRE akro-20190930_pre.xml EX-101.PRE 276733
Mailing Address 170 HARBOR WAY SOUTH SAN FRANCISCO CA 94080
Business Address 170 HARBOR WAY SOUTH SAN FRANCISCO CA 94080 650-487-6488
Akero Therapeutics, Inc. (Filer) CIK: 0001744659 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38944 | Film No.: 191206109
SIC: 2834 Pharmaceutical Preparations